Patient Opportunity Trust Class A LGOAX

Morningstar Medalist Rating
  • NAV / 1-Day Return $54.31  /  +0.18 %
  • Fund Size $2.0B
  • Adjusted Expense Ratio 1.230%
  • Net Expense Ratio 1.690%
  • Fee Level: Distribution Above Average
  • Share Class Type Front Load
  • Morningstar Category Mid-Cap Value
  • Equity Style Box (Funds) Large Blend
  • Minimum Initial Investment $1,000
  • Investment Status Open
  • TTM Yield 0.00%
  • Turnover Ratio 27%

Morningstar’s Analysis LGOAX

Will LGOAX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

In good hands.

Analyst David Carey

David Carey

Analyst

Summary

Increased conviction in Patient Opportunity’s lead manager and supporting cast warrants a People Pillar upgrade to Above Average from Average, while its Process Pillar remains Average.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LGOAX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 50.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Royalty Pharma PLC Class A

6.13 140M
Healthcare

Citigroup Inc

5.67 129M
Financial Services

Alphabet Inc Class A

5.65 129M
Communication Services

Precigen Warrant Restricted

5.59 128M
—

Amazon.com Inc

5.18 118M
Consumer Cyclical

NVIDIA Corp

5.00 114M
Technology

UnitedHealth Group Inc

4.82 110M
Healthcare

Precigen Inc

4.50 103M
Healthcare

Meta Platforms Inc Class A

3.81 87M
Communication Services

QXO Inc

3.68 84M
Industrials

Sponsor Center